Impact of Non-Medical Treatments of Endometrioma on Pregnancy Outcomes – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“From our November issue, 51.5, this meta-analysis from assesses the impact of non-medical endometrioma treatments on pregnancy rates in infertile women with endometrioma.
To date, no randomized clinical trials have demonstrated a higher efficacy of one specific technique in terms of either pregnancy rate or recurrence rate.
The results of this review suggest cystectomy and ablation have similar pregnancy and recurrence rates, making them suitable for treating endometriomas in infertile women; with sclerotherapy and no treatment also providing acceptable pregnancy rates. However, fenestration and coagulation are not recommended due to poor outcomes in terms of pregnancy and recurrence rates.
The authors recommend personalised tailoring of treatments, taking into account clinical features and preferences, with the goals of alleviating pain, enhancing fertility, improving quality of life and minimizing the need for further surgery.
As with all RBMO Review articles, this paper is free to read, available from our November issue.”
Title: Impact of non-medical treatments of endometrioma on pregnancy outcome: a systematic review and meta-analysis
Authors: Elham Askary, Francisco Carmona, Saeed Alborzi, Cristian de Guirior

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now
